²é¿´: 820  |  »Ø¸´: 2
±¾Ìû²úÉú 1 ¸ö ·­ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴

cyzenglish

Òø³æ (ÖøÃûдÊÖ)


[½»Á÷] Çë¸ßÊÖ°ïÖú·­Ò룬²»Ê¤¸Ð¼¤

Plasmid pR1C-4.1CAT that contains 4.1 kb 5¡ä-flanking sequence of mouse Ren-1c gene  was provided by K.W. Gross (Roswell Park Cancer Institute, Buffalo, New York, USA). To generate pGL-117bp reporter plasmid, the 123-bp renin minimal promoter fragment (+6 to ¨C117) was released from pR1C-4.1CAT with XbaI and BamHI and inserted into the HindIII site of pGL3-basic vector (Promega Corp.). To generate pGL-4.1kb reporter plasmid, the BamHI fragment (¨C4.1 kb to ¨C118 bp) from pR1C-4.1CAT was inserted into the BglII site of pGL-117bp. To analyze the activity of renin gene promoter, As4.1-hVDR cells were transfected with the reporter plasmids by electroporation according to the method of Shi et al using a Gene Pulser (Bio-Rad Laboratories Inc.). pCMV¨C¦Â-galactosidase (¦Â-gal) plasmid was cotransfected as an internal control. pGL3-control plasmid (Promega Corp.) was used as the positive control. The transfected cells were treated with ethanol or 10¨C8 M 1,25(OH)2D3 in Opti-MEM medium (Invitrogen Life Technologies) containing 2% charcoal-treated FBS 4 hours after electroporation, and luciferase activity was determined at 48 hours after initial transfection using the Luciferase Assay System (Promega Corp.). Luciferase activity was normalized to ¦Â-gal activity obtained from the same electroporation, and presented as fold induction based on the basal activity of pGL3-basic empty vector determined in the same experiment.

» ²ÂÄãϲ»¶

» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:

²é¿´È«²¿É¢½ðÌù

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
10¸ö½ð±Ò¶¼ÏÓÀÛ
2Â¥2011-02-05 17:48:58
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
cyzenglish(½ð±Ò+2, ·­ÒëEPI+1): 2011-02-07 14:47:43
º¬ÓÐСÊó Ren-1c »ùÒò4.1kb  5¡ä-²àÒíÐòÁеÄÖÊÁ£ pR1C-4.1CAT ÓÉ K.W. Gross (Roswell Park Cancer Institute, Buffalo, New York, USA)Ìṩ¡£
3Â¥2011-02-05 17:53:39
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ cyzenglish µÄÖ÷Ìâ¸üÐÂ
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û